Literature DB >> 26919075

NORE1A is a double barreled Ras senescence effector that activates p53 and Rb.

Howard Donninger1, Thibaut Barnoud2, Geoffrey J Clark3.   

Abstract

Although Ras is a potent oncogene in human tumors it has the paradoxical ability to promote Oncogene Induced Senescence (OIS). This appears to serve as a major barrier to Ras driven transformation in vivo. The signaling pathways used by Ras to promote senescence remain relatively poorly understood, but appear to invoke both the p53 and the Rb master tumor suppressors. Exactly how Ras communicates with p53 and Rb has remained something of a puzzle. NORE1A is a direct Ras effector that is frequently downregulated in human tumors. We have now found that it serves as a powerful Ras senescence effector. Moreover, we have defined signaling mechanisms that allows Ras to control both p53 and Rb post-translational modifications via the NORE1A scaffolding molecule. Indeed, NORE1A can be detected in complex with both p53 and Rb. Thus, by coupling Ras to both tumor suppressors, NORE1A forms a major component of the Ras senescence machinery and serves as the missing link between Ras and p53/Rb.

Entities:  

Keywords:  NORE1A; Ras; Rb; p53; senescence

Mesh:

Substances:

Year:  2016        PMID: 26919075      PMCID: PMC5004699          DOI: 10.1080/15384101.2016.1152431

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  7 in total

Review 1.  RAS oncogenes: the first 30 years.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2003-06       Impact factor: 60.716

Review 2.  The essence of senescence.

Authors:  Thomas Kuilman; Chrysiis Michaloglou; Wolter J Mooi; Daniel S Peeper
Journal:  Genes Dev       Date:  2010-11-15       Impact factor: 11.361

Review 3.  Drugging the undruggable RAS: Mission possible?

Authors:  Adrienne D Cox; Stephen W Fesik; Alec C Kimmelman; Ji Luo; Channing J Der
Journal:  Nat Rev Drug Discov       Date:  2014-10-17       Impact factor: 84.694

4.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

Review 5.  Senescence in tumours: evidence from mice and humans.

Authors:  Manuel Collado; Manuel Serrano
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

6.  Ras Regulates Rb via NORE1A.

Authors:  Thibaut Barnoud; Howard Donninger; Geoffrey J Clark
Journal:  J Biol Chem       Date:  2015-12-16       Impact factor: 5.157

7.  NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2.

Authors:  Howard Donninger; Diego F Calvisi; Thibaut Barnoud; Jennifer Clark; M Lee Schmidt; Michele D Vos; Geoffrey J Clark
Journal:  J Cell Biol       Date:  2015-03-16       Impact factor: 10.539

  7 in total
  3 in total

Review 1.  The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.

Authors:  Thibaut Barnoud; M Lee Schmidt; Howard Donninger; Geoffrey J Clark
Journal:  Cancer Lett       Date:  2017-04-26       Impact factor: 8.679

Review 2.  Pumping the brakes on RAS - negative regulators and death effectors of RAS.

Authors:  Desmond R Harrell Stewart; Geoffrey J Clark
Journal:  J Cell Sci       Date:  2020-02-10       Impact factor: 5.285

3.  Nonstructural protein 5B promotes degradation of the NORE1A tumor suppressor to facilitate hepatitis C virus replication.

Authors:  Payal Arora; Amartya Basu; M Lee Schmidt; Geoffrey J Clark; Howard Donninger; Daniel B Nichols; Diego F Calvisi; Neerja Kaushik-Basu
Journal:  Hepatology       Date:  2017-03-30       Impact factor: 17.425

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.